Dow Chemical and DuPont hit another roadblock on their path to gaining regulatory approval for their proposed merger after the European Union antitrust regulator said on Friday it suspended its review into the deal for the second time.
The European Commission, the bloc’s antitrust authority, said the companies again didn’t provide important information requested of them. The regulator was forced to pause the review in September for the same reason, before resuming its probe again in early October.
“Dow and DuPont have always expected a thorough review,” a Dow spokeswoman said, adding that the companies continue to “work constructively with the European Commission and regulatory agencies in relevant jurisdictions.”
Given the current status of the regulatory reviews, the companies expect to close the deal in the first quarter of 2017, the spokeswoman added.
The European Commission in August had opened an in-depth investigation to determine whether the combination may reduce competition in crop protection, seeds and certain petrochemicals.
The proposed merger, disclosed in December, would unite the two companies with a combined market cap of roughly $122 billion, before splitting into three separate companies.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Lawmaker Probes FTC and EU’s Role in Amazon’s Failed iRobot Acquisition
May 2, 2024 by
CPI
FTC to Approve Exxon’s $64 Billion Deal with Pioneer Resources, Excludes
May 1, 2024 by
CPI
UK Competition Watchdog Raises Alarm Over Nvidia’s ARM Takeover
May 1, 2024 by
CPI
Sen. Klobuchar Urges Regulators to Probe Collusion in Healthcare Pricing
May 1, 2024 by
CPI
Multiple States Join Tennessee’s Antitrust Lawsuit Against NCAA Over NIL Rules
May 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI